Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A transitional cell carcinoma that involves the body of uterus.
1 clinical trial registered. Interventions under study include procedural interventions and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
2 publications have been identified in PubMed for transitional cell carcinoma of the corpus uteri. Research spans Other (50%) and Case Report / Case Series (50%).
Rikitake R (2025). [PMID: 40376725](https://pubmed.ncbi.nlm.nih.gov/40376725/). *Pathol Int*. [Other]
Ding L (2024). [PMID: 38996162](https://pubmed.ncbi.nlm.nih.gov/38996162/). *Medicine (Baltimore)*. [Case Report / Case Series]
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 6:12 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center